<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00267449</url>
  </required_header>
  <id_info>
    <org_study_id>SSC-311</org_study_id>
    <nct_id>NCT00267449</nct_id>
  </id_info>
  <brief_title>Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System</brief_title>
  <official_title>Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ART Advanced Research Technologies Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ART Advanced Research Technologies Inc.</source>
  <brief_summary>
    <textblock>
      The primary study endpoint -SoftScan adjunctive accuracy- will be used to test the hypothesis&#xD;
      that the adjunctive combination of the SoftScan with x-ray mammography provides diagnostic&#xD;
      accuracy that is significantly better than x-ray mammography alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, serially-recruited, blinded and unblinded, validation study to test that the&#xD;
      adjunctive combination of the SoftScan with x-ray mammography provides diagnostic accuracy&#xD;
      that is significantly better than x-ray mammography alone. Healthy volunteers and patients&#xD;
      scheduled for tissue biopsy/excision of a suspicious breast lesion will be enrolled. Reader&#xD;
      Studies will be performed in which interpreting investigators will perform blinded&#xD;
      mammography interpretations, and reinterpretations of mammography and SoftScan&#xD;
      interpretations. Diagnostic accuracy will be calculated using tissue histopathology as the&#xD;
      reference standard.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2005</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">950</enrollment>
  <condition>Breast Cancer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SoftScan Optical Breast Imaging System</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Women between the ages of 20 and 80 years of age, who are either healthy or who are&#xD;
        scheduled to undergo a tissue biopsy of surgical excision of a suspicious breast lesion for&#xD;
        histopathologic diagnosis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        For the Healthy Volunteers Population,&#xD;
&#xD;
          -  subjects with a history of minor breast procedures involving either breast;&#xD;
&#xD;
          -  subjects with a history of major breast procedures involving either breast;&#xD;
&#xD;
          -  subjects with a history of significant acute breast abnormalities involving either&#xD;
             breast; and&#xD;
&#xD;
          -  subjects with a history of significant chronic breast abnormalities involving either&#xD;
             breast; and&#xD;
&#xD;
        For Referred For Biopsy Population,&#xD;
&#xD;
          -  subjects with a history of minor breast procedures involving either breast that were&#xD;
             performed within 6 months prior to enrollment or which have not completed active&#xD;
             healing at the time of enrollment;&#xD;
&#xD;
          -  subjects with a history of major breast procedures involving either breast;&#xD;
&#xD;
          -  subjects with a history of significant acute breast abnormalities involving either&#xD;
             breast which have not completed active healing or resolution within 6 months prior to&#xD;
             enrollment; and&#xD;
&#xD;
          -  subjects with a history of significant chronic breast abnormalities involving either&#xD;
             breast.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph G Kozikowski, MD</last_name>
    <role>Study Director</role>
    <affiliation>ART Advanced Research Technologies Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Margaret Polyzos</last_name>
    <phone>(514) 832-0777</phone>
    <phone_ext>267</phone_ext>
    <email>mpolyzos@art.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California-San Diego - Rebecca and John Moores Cancer Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise Darrah</last_name>
      <phone>858-657-7027</phone>
    </contact>
    <investigator>
      <last_name>Christopher Comstock, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University - Stanford Breast Imaging Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leslie Roche</last_name>
      <phone>650-724-5913</phone>
      <email>lesroche@stanford.edu.</email>
    </contact>
    <investigator>
      <last_name>Debra M Ikeda, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sanjiv S Gambhir, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Martin Memorial Health Systems, Stuart - Robert &amp; Carol Weissman Cancer Center</name>
      <address>
        <city>Stuart</city>
        <state>Florida</state>
        <zip>34994</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>772-228-5858</phone>
    </contact>
    <investigator>
      <last_name>James J Vopal, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CAMIS - Central Alberta Medical Imaging Services</name>
      <address>
        <city>Red Deer</city>
        <state>Alberta</state>
        <zip>T4N 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>403-343-6172</phone>
      <phone_ext>2259</phone_ext>
    </contact>
    <investigator>
      <last_name>Bernice Capusten, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Health Network (UNH) - Princess Margaret Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>(416) 946-4501</phone>
    </contact>
    <investigator>
      <last_name>Pavel Crystal, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MUHC- McGill University Health Center</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Intes X. Time-domain optical mammography SoftScan: initial results. Acad Radiol. 2005 Aug;12(8):934-47. Erratum in: Acad Radiol. 2005 Oct;12(10):1355.</citation>
    <PMID>16023382</PMID>
  </reference>
  <verification_date>September 2007</verification_date>
  <study_first_submitted>December 19, 2005</study_first_submitted>
  <study_first_submitted_qc>December 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2005</study_first_posted>
  <last_update_submitted>September 10, 2007</last_update_submitted>
  <last_update_submitted_qc>September 10, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2007</last_update_posted>
  <keyword>Spectroscopy, Near-Infrared</keyword>
  <keyword>Mammography</keyword>
  <keyword>Breast Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

